Stoke Therapeutics’ Zorevunersen Shows Promise in Treating Dravet Syndrome For children with Dravet syndrome, a rare and severe genetic epilepsy, developmental delays often begin after an initial period of normal …
Tag:
Fierce Biotech Homepage
-
-
Novo Nordisk’s UBT251 Shows Promise in Obesity Treatment Following CagriSema Setback Novo Nordisk is seeking a path forward in the competitive obesity drug market following the recent failure of its …
-
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren …